Your browser doesn't support javascript.
loading
Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal antibody therapy for RAS wild-type metastatic colorectal cancer.
Rowland, A; Dias, M M; Wiese, M D; Kichenadasse, G; McKinnon, R A; Karapetis, C S; Sorich, M J.
Afiliación
  • Rowland A; 1] Department of Clinical Pharmacology, School of Medicine, Flinders University, Bedford Park, Adelaide, South Australia 5042, Australia [2] Flinders Centre for Innovation in Cancer, School of Medicine, Flinders University, Adelaide, South Australia 5042, Australia.
  • Dias MM; 1] Department of Clinical Pharmacology, School of Medicine, Flinders University, Bedford Park, Adelaide, South Australia 5042, Australia [2] School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, South Australia 5000, Australia.
  • Wiese MD; School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, South Australia 5000, Australia.
  • Kichenadasse G; Flinders Centre for Innovation in Cancer, School of Medicine, Flinders University, Adelaide, South Australia 5042, Australia.
  • McKinnon RA; Flinders Centre for Innovation in Cancer, School of Medicine, Flinders University, Adelaide, South Australia 5042, Australia.
  • Karapetis CS; Flinders Centre for Innovation in Cancer, School of Medicine, Flinders University, Adelaide, South Australia 5042, Australia.
  • Sorich MJ; 1] Department of Clinical Pharmacology, School of Medicine, Flinders University, Bedford Park, Adelaide, South Australia 5042, Australia [2] Flinders Centre for Innovation in Cancer, School of Medicine, Flinders University, Adelaide, South Australia 5042, Australia.
Br J Cancer ; 112(12): 1888-94, 2015 Jun 09.
Article en En | MEDLINE | ID: mdl-25989278
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Proteínas Proto-Oncogénicas B-raf / Receptores ErbB / Mutación Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Br J Cancer Año: 2015 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Proteínas Proto-Oncogénicas B-raf / Receptores ErbB / Mutación Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Br J Cancer Año: 2015 Tipo del documento: Article País de afiliación: Australia